Importantly, cohesin mutations are prevalent in AML and other myeloid malignancies34, and are categorised together with RUNX1 and spliceosome mutations in a genetic category that confers poor prognosis in AML5. The gene discussed is RUNX1; the disease is acute myeloid leukemia.